Author:
Zamani Farhad,Karimi Hanie,Mansoorian Mohsenreza,Basi Ali,Hosseini S. Ahmad,Zahed Zahra,Seyedghasemipour Nasim,Sahraie Roghayeh
Abstract
Abstract
Introduction
Acute myeloid leukemia is a rare event in post-liver-transplantation recipients. In the present report, we described a case of extramedullary acute myeloid leukemia, M4/M5 subtype, following orthotopic liver transplant.
Case presentation
The patient was a 50-year-old Iranian woman who underwent orthotopic liver transplant due to hepatitis B-related cirrhosis (Child C, MELD (model for end-stage liver disease score) = 22). Orthotopic liver transplant was performed using the piggy back technique in January 2022. Induction immunosuppressive therapy was 1 gm methylprednisolone for 3 days followed by a triple maintenance immunosuppressive regimen including mycophenolate mofetil, prednisolone, and tacrolimus. About 5 months after orthotopic liver transplant in June 2022, the patient presented with leukocytosis, with white blood cell count of 99.4 × 103/µl, and physical examination revealed only cervical lymphadenopathy. Biopsy of cervical lymph nodes showed a myeloid tumor. She was immediately hospitalized. Eight hours after hospitalization, the patient gradually developed lethargy and decreased O2 saturation to approximately 89%. Flow cytometry demonstrated the markers of a myelomonocytic acute myeloid leukemia (M4/M5). Cytoreduction was immediately started by intensive leukopheresis followed by induction therapy. Because of a septic complication during the induction therapy, further chemotherapy was discontinued and broad-spectrum antibiotics and antifungal treatments started. Unfortunately, our patient died of severe septic shock 42 days after hospitalization.
Conclusion
Acute myeloid leukemia is a rare phenomenon after liver transplantation, and it can follow a rapidly fatal clinical course.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Starzl TE, Groth CG, Brettschneider L, Penn I, Fulginiti VA, Moon JB, Blanchard H, Martin AJ Jr, Porter KA. Orthotopic homotransplantation of the human liver. Ann Surg. 1968;168:392.
2. Liver EAfTSot: EASL clinical practice guidelines: liver transplantation. J Hepat 2016, 64:433–485.
3. Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg. 1996;2:52–9.
4. Thalhammer-Scherrer R, Wieselthaler G, Knoebl P, Schwarzinger I, Simonitsch I, Mitterbauer G, Berlakovich G, Mannhalter C, Haas O, Mayer G. Post-transplant acute myeloid leukemia (PT-AML). Leukemia. 1999;13:321–6.
5. Doycheva I, Amer S, Watt KD. De novo malignancies after transplantation: risk and surveillance strategies. Medical Clinics. 2016;100:551–67.